118 related articles for article (PubMed ID: 38146796)
21. Multiparametric MRI radiomics in prostate cancer for predicting Ki-67 expression and Gleason score: a multicenter retrospective study.
Zhou C; Zhang YF; Guo S; Wang D; Lv HX; Qiao XN; Wang R; Chang DH; Zhao LM; Zhou FH
Discov Oncol; 2023 Jul; 14(1):133. PubMed ID: 37470865
[TBL] [Abstract][Full Text] [Related]
22. Prediction of pelvic lymph node metastasis in prostate cancer using radiomics based on T
Liu X; Zhang Y; Sun Z; Wang X; Zhang X; Wang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1025-1036. PubMed ID: 36097770
[TBL] [Abstract][Full Text] [Related]
23. Predicting prostate cancer in men with PSA levels of 4-10 ng/mL: MRI-based radiomics can help junior radiologists improve the diagnostic performance.
Zhong JG; Shi L; Liu J; Cao F; Ma YQ; Zhang Y
Sci Rep; 2023 Mar; 13(1):4846. PubMed ID: 36964192
[TBL] [Abstract][Full Text] [Related]
24. A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics.
Bleker J; Kwee TC; Rouw D; Roest C; Borstlap J; de Jong IJ; Dierckx RAJO; Huisman H; Yakar D
Eur Radiol; 2022 Sep; 32(9):6526-6535. PubMed ID: 35420303
[TBL] [Abstract][Full Text] [Related]
25. Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer.
Li M; Yang L; Yue Y; Xu J; Huang C; Song B
Front Oncol; 2020; 10():631831. PubMed ID: 33680954
[TBL] [Abstract][Full Text] [Related]
26. MRI Radiomics-Based Machine Learning Models for Ki67 Expression and Gleason Grade Group Prediction in Prostate Cancer.
Qiao X; Gu X; Liu Y; Shu X; Ai G; Qian S; Liu L; He X; Zhang J
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760505
[TBL] [Abstract][Full Text] [Related]
27. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
[TBL] [Abstract][Full Text] [Related]
29. Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy.
Dutta A; Chan J; Haworth A; Dubowitz DJ; Kneebone A; Reynolds HM
Phys Imaging Radiat Oncol; 2024 Jan; 29():100530. PubMed ID: 38275002
[TBL] [Abstract][Full Text] [Related]
30. External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer.
Bourbonne V; Fournier G; Vallières M; Lucia F; Doucet L; Tissot V; Cuvelier G; Hue S; Le Penn Du H; Perdriel L; Bertrand N; Staroz F; Visvikis D; Pradier O; Hatt M; Schick U
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32231077
[TBL] [Abstract][Full Text] [Related]
31. Performance variability of radiomics machine learning models for the detection of clinically significant prostate cancer in heterogeneous MRI datasets.
Gresser E; Schachtner B; Stüber AT; Solyanik O; Schreier A; Huber T; Froelich MF; Magistro G; Kretschmer A; Stief C; Ricke J; Ingrisch M; Nörenberg D
Quant Imaging Med Surg; 2022 Nov; 12(11):4990-5003. PubMed ID: 36330197
[TBL] [Abstract][Full Text] [Related]
32. Predicting survival of men with recurrent prostate cancer after radical prostatectomy.
Dell'Oglio P; Suardi N; Boorjian SA; Fossati N; Gandaglia G; Tian Z; Moschini M; Capitanio U; Karakiewicz PI; Montorsi F; Karnes RJ; Briganti A
Eur J Cancer; 2016 Feb; 54():27-34. PubMed ID: 26707594
[TBL] [Abstract][Full Text] [Related]
33. Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.
Park SY; Kim CK; Park BK; Lee HM; Lee KS
Eur Radiol; 2011 May; 21(5):1111-8. PubMed ID: 21046403
[TBL] [Abstract][Full Text] [Related]
34. [The value of DISCO and MUSE-DWI combined with prostate specific antigen density in the diagnosis and risk stratification of prostate cancer].
Chen ZQ; Zhang D; Wang Z; Song N; Ma AL; Zhang SR; Cai L
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1461-1468. PubMed ID: 37198108
[No Abstract] [Full Text] [Related]
35. A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions.
Liang L; Zhi X; Sun Y; Li H; Wang J; Xu J; Guo J
Front Oncol; 2021; 11():610785. PubMed ID: 33738255
[TBL] [Abstract][Full Text] [Related]
36. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
Dwivedi DK; Kumar R; Dwivedi AK; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226
[TBL] [Abstract][Full Text] [Related]
37. Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer.
Ma L; Zhou Q; Yin H; Ang X; Li Y; Xie G; Li G
Transl Cancer Res; 2022 May; 11(5):1146-1161. PubMed ID: 35706813
[TBL] [Abstract][Full Text] [Related]
38. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
40. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
